NCT07325994 Verbal Analgesia Versus Standard Care for Pain Control in Women With Primary Infertility Undergoing Office Hysteroscopy
| NCT ID | NCT07325994 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Hysteroscopy |
| Study Type | INTERVENTIONAL |
| Enrollment | 92 participants |
| Start Date | 2025-10-20 |
| Primary Completion | 2026-03-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 92 participants in total. It began in 2025-10-20 with a primary completion date of 2026-03-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Office hysteroscopy is a cornerstone in the diagnostic evaluation of infertile women, enabling direct visualization of the uterine cavity for identifying intrauterine pathology. The vaginoscopic ("no-touch") approach, which eliminates the use of a speculum and tenaculum, is increasingly adopted due to improved tolerability, higher success rates, and reduced pain compared to conventional methods.
Eligibility Criteria
Inclusion Criteria: * o Women aged 18-40 years. * Diagnosis of primary infertility (failure to conceive after ≥12 months of unprotected intercourse). * Indication for diagnostic office hysteroscopy. * Regular menstrual cycles. Exclusion Criteria: * o Secondary infertility. * Known pelvic infection, cervicitis, or vaginitis. * Use of analgesics within 8 hours prior to procedure. * Cervical stenosis, prior failed hysteroscopy, or known uterine anomaly. * Contraindication to NSAIDs * Pregnancy or suspected pregnancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07325994 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Hysteroscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07325994 currently recruiting?
Yes, NCT07325994 is actively recruiting participants. Contact the research team at mahmoudalalfy@ymail.com for enrollment information.
Where is the NCT07325994 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT07325994 clinical trial?
NCT07325994 is sponsored by Cairo University. The trial plans to enroll 92 participants.